Investor Relations

News Releases

News Releases

Feb 18, 2021
PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, has been awarded Defense Health Agency funds to support a five-year Research Project Award (RPA) to develop and execute an adaptive platform clinical research trial of drug interventions to treat post-traumatic stress disorder (PTSD). 
Jan 04, 2021
PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, will present virtually at the 39th Annual J.P. Morgan Healthcare Conference. David Simmons, chairman and CEO, and Chris Scully, CFO, are scheduled to present on Monday, Jan. 11, 2021, at 2:50 p.m. (U.S. Eastern Time).